SCHEMBL9004654

SCHEMBL9004654

O=C(NN=c1c(=O)c2ccccc2c1=O)Nc1ccccc1Br

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.51
SENP6 Q9GZR1 4/20 0.51
CASP3 P42574 4/20 0.51
SENP8 Q96LD8 3/20 0.51
SENP7 Q9BQF6 3/20 0.51
MAPT P10636 3/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
ALDH1A1 P00352 2/20 0.51
APAF1 O14727 1/20 0.51
TDP2 O95551 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2D6 P10635 1/20 0.51
THRB P10828 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
HTT P42858 4/20 0.50
MEN1 O00255 4/20 0.50
RAB9A P51151 4/20 0.50
NPC1 O15118 3/20 0.50
LMNA P02545 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9004741 0.84 MAPT (0.53) KMT2ASENP6CASP3SENP8SENP7
SCHEMBL9004668 0.82 RAB9A (0.57) KMT2ASENP6CASP3SENP8SENP7
SCHEMBL9004650 0.82 MAPT (0.51) KMT2ASENP6CASP3SENP8SENP7
SCHEMBL9232385 0.82 SENP6 (0.51) KMT2ASENP6CASP3SENP8SENP7
SCHEMBL9004618 0.82 KMT2A (0.63) KMT2ASENP6CASP3SENP8SENP7
SCHEMBL9004705 0.79 MAOB (0.54) KMT2ASENP6CASP3SENP8SENP7
SCHEMBL9004683 0.79 SENP6 (0.56) KMT2ASENP6CASP3SENP8SENP7
SCHEMBL9004655 0.79 KMT2A (0.57) KMT2ASENP6CASP3SENP8SENP7
SCHEMBL8667830 0.78 SENP6 (0.61) KMT2ASENP6CASP3SENP8SENP7
SCHEMBL8667033 0.78 KMT2A (0.51) KMT2ASENP6CASP3SENP8SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5571843-A Derivatives of indan-1,3-dione and indan-1,2,3-trione, methods of preparing them and therapeutic use thereof INNOTHERA (FR) 1996-11-05 US disclosed
EP-0566445-B1 Derivatives of indane 1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy INNOTHERA LAB SA (FR) 1996-02-07 EP disclosed
EP-0566445-A1 Derivatives of indane 1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy INNOTHERA (FR) 1993-10-20 EP disclosed
WO-1993020045-A1 INDAN-1,3-DIONE AND INDAN-1,2,3-TRIONE DERIVATIVES, PROCESSES FOR THE PREPARATION OF SAME AND THEIR APPLICATION AS THERAPEUTIC AGENTS INNOTHERA (FR) 1993-10-14 WO disclosed